Sorbent membrane dialysis in uremia

Area of Science:

• Nephrology
• Biomaterials Science
• Medical Device Engineering

Background:

• Activated charcoal in hemodialysis membranes aims to enhance plasma clearance of uremic toxins like creatinine and middle molecules.
• Charcoal saturation limits its efficacy over time, reverting solute removal to standard dialysis alone after one hour.

Purpose of the Study:

• To evaluate the effectiveness of sorbent membrane dialysis (SMD) in treating uremia.
• To compare solute levels and clinical status of patients undergoing SMD versus conventional hemodialysis.

Main Methods:

• Two independent crossover studies were conducted.
• Patients were treated with both SMD and conventional hemodialysis to compare outcomes.

Main Results:

• SMD resulted in higher predialysis urea (approx. 15%), creatinine (10-15%), and inorganic phosphate (10-18%) levels compared to conventional hemodialysis.
• Elevated "middle molecule" (peak "b") levels were observed in one study.
• No significant differences in clinical patient status were noted between the two dialysis methods.

Conclusions:

• The amount of activated charcoal in the SMD device is insufficient to provide advantages over conventional hemodialysis.
• Current SMD technology does not offer improved uremic toxin clearance.
• Further research may be needed to optimize sorbent materials for enhanced hemodialysis efficacy.